Facebook
Linkedin
Twitter
Industries
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Quick Byte
Resources
Search
Wednesday, April 2, 2025
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ReadMagazine
Industries
All
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
DHL Group Acquires CRYOPDP from Cryoport to Strengthen Health Logistics Capabilities
Norfolk Southern Launches RailGreen: Industry-First Program to Reduce Freight Rail Emissions
Twist Bioscience and Curio Genomics Partner to Accelerate NGS Adoption in…
o9 solutions Has Signed a SaaS Agreement With Toyota Motor Corporation…
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Quick Byte
Resources
Home
Tags
IMiD
IMiD
Healthcare
Bristol Myers Squibb’s Abecma (idecabtagene vicleucel) Becomes First CAR T Cell Therapy Approved in the European Union in Earlier Lines for Triple-Class Exposed Relapsed...
News Desk
-
March 21, 2024
Bristol Myers Squibb announced that the European Commission (EC) has granted approval to Abecma® (idecabtagene vicleucel; ide-cel) for the treatment of adult patients with relapsed and...
0
Fans
Like
3,912
Followers
Follow
0
Subscribers
Subscribe
Hot Topics
DHL Group Acquires CRYOPDP from Cryoport to Strengthen Health Logistics Capabilities
Norfolk Southern Launches RailGreen: Industry-First Program to Reduce Freight Rail Emissions
Twist Bioscience and Curio Genomics Partner to Accelerate NGS Adoption in Agrigenomics
Load more
